Ascentage Pharma Group International (AAPG) Other Non-Current Assets: 2022-2024

  • Ascentage Pharma Group International's Other Non-Current Assets rose 138.42% to $8.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $8.1 million, marking a year-over-year increase of 138.42%. This contributed to the annual value of $8.1 million for FY2024, which is 134.01% up from last year.
  • Ascentage Pharma Group International's Other Non-Current Assets amounted to $8.1 million in Q4 2024, which was up 138.42% from $3.4 million recorded in Q4 2023.
  • Ascentage Pharma Group International's Other Non-Current Assets' 5-year high stood at $8.1 million during Q4 2024, with a 5-year trough of $2.3 million in Q4 2022.
  • For the 3-year period, Ascentage Pharma Group International's Other Non-Current Assets averaged around $4.6 million, with its median value being $3.4 million (2023).
  • Data for Ascentage Pharma Group International's Other Non-Current Assets shows a peak YoY skyrocketed of 138.42% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Ascentage Pharma Group International's Other Non-Current Assets stood at $2.3 million in 2022, then soared by 46.00% to $3.4 million in 2023, then surged by 138.42% to $8.1 million in 2024.
  • Its last three reported values are $8.1 million in Q4 2024, $3.4 million for Q4 2023, and $2.3 million during Q4 2022.